Karyopharm Therapeutics Inc (KPTI)
1.255
-0.02
(-1.57%)
USD |
NASDAQ |
Apr 19, 10:58
Karyopharm Therapeutics Profit Margin (Quarterly): -124.0% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -124.0% |
| September 30, 2023 | -95.83% |
| June 30, 2023 | -86.83% |
| March 31, 2023 | -88.19% |
| December 31, 2022 | -114.7% |
| September 30, 2022 | -100.5% |
| June 30, 2022 | -123.6% |
| March 31, 2022 | -86.84% |
| December 31, 2021 | 30.66% |
| September 30, 2021 | -137.5% |
| June 30, 2021 | -237.1% |
| March 31, 2021 | -246.8% |
| December 31, 2020 | -123.7% |
| September 30, 2020 | -250.8% |
| June 30, 2020 | -138.5% |
| March 31, 2020 | -291.8% |
| December 31, 2019 | -268.8% |
| September 30, 2019 | -314.6% |
| June 30, 2019 | -457.3% |
| March 31, 2019 | -42.68K% |
| December 31, 2018 | -28.26K% |
| September 30, 2018 | -20.12K% |
| June 30, 2018 | -169.2% |
| Date | Value |
|---|---|
| March 31, 2018 | -384.6% |
| December 31, 2017 | -2.54K% |
| September 30, 2017 | |
| June 30, 2017 | -979.6K% |
| March 31, 2017 | -44.00K% |
| December 31, 2016 | -57.31K% |
| September 30, 2016 | -52.97K% |
| June 30, 2016 | -51.12K% |
| March 31, 2016 | |
| December 31, 2015 | -116.2K% |
| September 30, 2015 | -40.50K% |
| June 30, 2015 | -21.80K% |
| March 31, 2015 | |
| December 31, 2014 | -172.9K% |
| September 30, 2014 | -93.92K% |
| June 30, 2014 | -78.24K% |
| March 31, 2014 | -8.01K% |
| December 31, 2013 | -57.84K% |
| September 30, 2013 | |
| June 30, 2013 | -5.16K% |
| March 31, 2013 | -2.41K% |
| December 31, 2012 | -12.84K% |
| September 30, 2012 | -10.69K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-457.3%
Minimum
Jun 2019
30.66%
Maximum
Dec 2021
-171.4%
Average
-124.0%
Median
Dec 2023
Profit Margin (Quarterly) Benchmarks
| Geron Corp | -226.0K% |
| Arbutus Biopharma Corp | -900.3% |
| Verastem Inc | -- |
| Actinium Pharmaceuticals Inc | -11.51K% |
| Chimerix Inc | -454.0K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -47.95% |
| Return on Invested Capital | -148.2% |
| Gross Profit Margin (Quarterly) | 95.60% |
| Operating Margin (Quarterly) | -112.0% |
| Return on Net Operating Assets | -314.2% |